These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 15621751

  • 1. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
    Rojewski MT, Körper S, Schrezenmeier H.
    Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY, Yang CH, Chen YC.
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K, Kizaki M, Muto A, Fukuchi Y, Umezawa A, Yamato K, Nishihara T, Hata J, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [Abstract] [Full Text] [Related]

  • 4. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
    Chen Z, Chen GQ, Shen ZX, Chen SJ, Wang ZY.
    Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
    [Abstract] [Full Text] [Related]

  • 5. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.
    Zhao WL, Chen SJ, Shen Y, Xu L, Cai X, Chen GQ, Shen ZX, Chen Z, Wang ZY.
    Leuk Lymphoma; 2001 Jan; 42(6):1265-73. PubMed ID: 11911407
    [Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
    Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH.
    J Natl Cancer Inst; 1998 Jan 21; 90(2):124-33. PubMed ID: 9450572
    [Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide: acute promyelocytic leukemia and beyond.
    Bachleitner-Hofmann T, Kees M, Gisslinger H.
    Leuk Lymphoma; 2002 Aug 21; 43(8):1535-40. PubMed ID: 12400595
    [Abstract] [Full Text] [Related]

  • 8. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
    Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z.
    Blood; 1996 Aug 01; 88(3):1052-61. PubMed ID: 8704214
    [Abstract] [Full Text] [Related]

  • 9. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.
    Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY.
    Blood; 1997 May 01; 89(9):3354-60. PubMed ID: 9129042
    [Abstract] [Full Text] [Related]

  • 10. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A, Kizaki M, Kawamura C, Matsushita H, Fukuchi Y, Umezawa A, Yamada T, Hata J, Hozumi N, Yamato K, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2001 Aug 01; 15(8):1176-84. PubMed ID: 11480559
    [Abstract] [Full Text] [Related]

  • 11. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.
    Zhang P.
    J Biol Regul Homeost Agents; 1999 Aug 01; 13(4):195-200. PubMed ID: 10703942
    [Abstract] [Full Text] [Related]

  • 12. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR, Jena RK.
    Am J Hematol; 2005 Feb 01; 78(2):113-6. PubMed ID: 15682419
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
    Leukemia; 2000 Oct 01; 14(10):1743-50. PubMed ID: 11021749
    [Abstract] [Full Text] [Related]

  • 14. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.
    Di Noto R, Boccuni P, Costantini S, Dello Russo A, Lo Pardo C, Copia C, Annunziata M, Cimino R, Ferrara F, Del Vecchio L.
    Tissue Antigens; 1999 Dec 01; 54(6):597-602. PubMed ID: 10674975
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of all-trans retinoic acid resistant and chemotherapy naïve acute promyelocytic patients with arsenic trioxide--two case reports.
    Lin CP, Huang MJ, Chang IY, Lin WY.
    Leuk Lymphoma; 2000 Jun 01; 38(1-2):191-4. PubMed ID: 10811462
    [Abstract] [Full Text] [Related]

  • 16. Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies.
    Liu P, Han ZC.
    Int J Hematol; 2003 Jul 01; 78(1):32-9. PubMed ID: 12894848
    [Abstract] [Full Text] [Related]

  • 17. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
    Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z.
    Blood; 1997 May 01; 89(9):3345-53. PubMed ID: 9129041
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
    Bergstrom SK, Gillan E, Quinn JJ, Altman AJ.
    J Pediatr Hematol Oncol; 1998 May 01; 20(6):545-7. PubMed ID: 9856675
    [Abstract] [Full Text] [Related]

  • 19. Catalase activity and arsenic sensitivity in acute leukemia.
    Coe E, Schimmer AD.
    Leuk Lymphoma; 2008 Oct 01; 49(10):1976-81. PubMed ID: 18949620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.